These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 107555)

  • 1. [Progressive myoclonic encephalopathy in dialysis patients. Clinical, electroencephalographic and neuropathological study. Pathogenetic discussion].
    Sabouraud O; Chatel M; Menault F; Dien Peron J; Cartier F; Garre M; Gary J; Pecker S
    Rev Neurol (Paris); 1978 Oct; 134(10):575-600. PubMed ID: 107555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Reversible dialytic encephalopathy after interruption of aluminium intake. 6 cases (author's transl)].
    Buge A; Poisson M; Masson S; Bleibel JM; Mashaly R; Jaudon MC; Lafforgue B; Lebkiri B; Raymond P
    Nouv Presse Med; 1979 Sep; 8(34):2729-33. PubMed ID: 493078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Progressive myoclonic encephalopathy in dialysis patients. The role of the water used for haemodialysis (author's transl)].
    Cartier F; Allain P; Gary J; Chatel M; Menault F; Pecker S
    Nouv Presse Med; 1978 Jan; 7(2):97-102. PubMed ID: 652514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Progressive dialytic encephalopathy. Role of the aluminium and neurological study. One case (author's transl)].
    Buge A; Escourolle R; Poisson M; Gray F; Bleibel JM; Jaudon MC
    Nouv Presse Med; 1979 Mar; 8(13):1071-4. PubMed ID: 461135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive dialysis encephalopathy.
    Lederman RJ; Henry CE
    Ann Neurol; 1978 Sep; 4(3):199-204. PubMed ID: 718132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurofibrillary neuronal degeneration in dialysis dementia: a feature of aluminum toxicity.
    Scholtz CL; Swash M; Gray A; Kogeorgos J; Marsh F
    Clin Neuropathol; 1987; 6(3):93-7. PubMed ID: 3608291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Juvenile myoclonic epilepsy].
    Ercegovac MD; Vojvodić N; SokićDV ; Janković SM; Drulović J; Stojsavljević N; Lević Z
    Srp Arh Celok Lek; 1998; 126(9-10):335-44. PubMed ID: 9863404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversible microcytic hypochromic anaemia in dialysis patients due to aluminium intoxication.
    Short AI; Winney RJ; Robson JS
    Proc Eur Dial Transplant Assoc; 1980; 17():226-33. PubMed ID: 7243773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prolonged and reversible encephalopathy in a chronic haemodialysis patient. Probable responsibility of aluminium salts (author's transl)].
    Buge A; Poisson M; Masson S; Bleibel JM; Lafforgue B; Raymond P; Jaudon MC
    Nouv Presse Med; 1978 Jun; 7(23):2053-9. PubMed ID: 673773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symptomatic epilepsies imitating idiopathic generalized epilepsies.
    Oguni H
    Epilepsia; 2005; 46 Suppl 9():84-90. PubMed ID: 16302880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Myoclonus and epilepsies in children].
    Fejerman N
    Rev Neurol (Paris); 1991; 147(12):782-97. PubMed ID: 1780607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A clinical and electroencephalographic study of juvenile myoclonic epilepsy: its pathophysiological considerations based on the findings obtained from neuropsychological EEG activation].
    Matsuoka H
    Seishin Shinkeigaku Zasshi; 1989; 91(5):318-46. PubMed ID: 2510209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benign myoclonic epilepsy in infants: electroclinical features and long-term follow-up of 34 patients.
    Auvin S; Pandit F; De Bellecize J; Badinand N; Isnard H; Motte J; Villeneuve N; Lamblin MD; Vallée L
    Epilepsia; 2006 Feb; 47(2):387-93. PubMed ID: 16499765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chronological study of signs of myoclonic encephalopathy in hemodialysis patients (author's transl)].
    Vecchierini-Blineau MF; Thebaud HE; Dupouet L; Brochard D; Coville P; Feve JR; Guiheneuc P
    Sem Hop; 1981 Nov 18-25; 57(43-44):1823-30. PubMed ID: 6274030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of aluminium intoxication in long-term acetate Redy dialysis.
    Van de Vyver FL; Visser WJ; D'Haese PC; Silva FJ; Thomas H; De Broe ME
    Nephrol Dial Transplant; 1989; 4(6):555-62. PubMed ID: 2507978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Two forerunners of the encephalopathy of hemodialysed patients : osteomalacic osteodystrophy and electroencephalographic alterations. Influence of the aluminium concentration in the dialysis fluid (author's transl)].
    Vecchierini-Blineau MF; Thébaud HE; Brochard D; Coville P
    Nephrologie; 1980; 1(1):29-32. PubMed ID: 7301017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Myoclonic epilepsies in infancy].
    Palencia R
    Rev Neurol; 2000 Jun; 30 Suppl 1():S15-24. PubMed ID: 10904965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Aluminum poisoning in dialysis patients--diagnosis and therapy].
    Vogelsang U
    Schweiz Rundsch Med Prax; 1994 Jun; 83(24):738-56. PubMed ID: 8023059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dialysis encephalopathy.
    Alfrey AC
    Clin Nephrol; 1985; 24 Suppl 1():S15-9. PubMed ID: 3915955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of parathyroid function and parathyroidectomy in the outcome of aluminium-related dialysis encephalopathy.
    Campistrus de Gencarelli N; Cournot-Witmer G; Zingraff J; Drüeke T
    Nephrol Dial Transplant; 1986; 1(3):192-8. PubMed ID: 3110673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.